Intravenous Immunoglobulin Market is anticipated to Show Strong Growth in Future | Hypogammaglobulinemia Emerged as the Largest Industry Segment | Top Vendors; Shire, Octapharma, CSL, and Grifols

AnalystView Market Insights recently introduced Global Intravenous Immunoglobulin Market study to its report store. The global intravenous immunoglobulin market is expected to grow at growth rate of 6.3% to reach USD 14.7 billion by 2025.

This study focuses on the market status, growth projection, key manufacturer’s revenue share, drivers, restraints and opportunities with respect to the global Intravenous Immunoglobulin market. This published report studies global market in terms of disease types, and route of administration. Also, geographies such as North America, Europe, Asia Pacific, Middle East, and Africa and Latin America are studied in detail.
Intravenous immunoglobulin (IVIG), also called as gamma globulin, is a human plasma product, specifically used for the treatment of immunodeficiency-related disorders. It is highly purified blood derived product preparation. Immunoglobulins are categorized as immunoglobulin A, immunoglobulin M, immunoglobulin D, immunoglobulin G, and immunoglobulin E, divided based on the variety of heavy chain these molecules contain.

The growth of IVIG market is majorly driven by the rise in the incidence rate of immunodeficiency diseases. As per the Immune Deficiency Foundation (IDF), there are more than 250 rare immune disorders representing primary immunodeficiency disorders. The growth of this market is also attributed to the increasing incidences bleeding and autoimmune disorders, aging population, and development of new treatment indications such as myasthenia gravis. According to the estimates published by the WHO, the global population of people aged 65 years and above was 7% in 2000 and is expected to rise to 16% in 2050. However, high cost coupled with stringent regulations associated with IVIG therapy hampers the market growth over the future period.

Get access to exclusive PDF brochure of this study @
www.analystviewmarketinsights.com/request_sample/av147/

Key Takeaways
• Hypogammaglobulinemia is considered to be the largest market, accounted for around 1.6 billion in 2017
• IVIG therapy for the treatment of Congenital AIDS is growing significantly, i.e. 7.9% over the forecast period
• Increasing number of government and non-government authorities researching on IVIG products support the market growth in Europe. Authorities such as Plasma Protein Therapeutics Association (PPTA) and Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) regulate the IVIG products which provide healthy platform for the market growth in the European country.
• Competition in this market is considerably high. Companies such as Shire, Octapharma, CSL and Grifols are competing to capture significant revenue share
• Rising regulatory approvals for new therapeutics is considered to help companies in capturing large customer base. For instance, in January 2015, Grifols SA’s purification plant received the FDA approval for the production of intravenous immunoglobulin (IVIG) 10%, plasma protein marketed under bra0nds Gamunex and Flebogamma.

Click here to obtain more highlight on “Intravenous Immunoglobulin Market, by Types, by Route, and by Geography– Analysis, Share, Trends, Size, & Forecast from 2014 – 2025” study @
www.analystviewmarketinsights.com/report-highlight-intravenous-immunoglobulin-market-147/

The global Intravenous Immunoglobulin market is segmented on the basis of:

Market, by Disease Types
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Hypogammaglobulinemia
- Congenital AIDS
- Immunodeficiency diseases
- Chronic Lymphocytic Leukemia
- Myasthenia Gravis
- Multifocal motor neuropathy
- Others

Market, by Route of Administration
- Intravenous
- Subcutaneous

The following key players are profiled in this study:
- Shire
- Octapharma
- CSL
- Grifols

KEY VENDOR ANALYSIS:
1. Well-designed strategic framework design for these key players will help to understand the market movement including regional expansion, mergers & acquisitions, and new product developments
2. Thorough SWOT i.e. Strength, Weakness, Opportunities and Threat for individual company profiling is analyzed in order to present a detailed market opportunity assessment.

Key benefits of the report:
• The report presents a macro and micro-level outlook regarding the industry. Thus, it becomes easy for our clients to perceive the business landscape and take a glimpse of their own standing in it.
• A thorough analysis of relevant statistical data to estimate the market paradigms
• Exceptional understanding of region and country-specific markets. The report will answer some of the toughest questions regarding the market shares, sizes, forecasts segmentations, and growth specific to the countries.
• Well-designed strategic framework analyzes the market movements including regional expansion, mergers & acquisitions, and new product developments

Research Methodology:
- Preliminary Data Mining: Secondary Research, Paid Databases, Primary Research
- Data Synthesis & Analysis: Top-Down Approach, Bottom-Up Approach, Supply Side and Demand Side
- Market Formulation: Market Dynamics, Total Addressable Market and Machine Learning Technique
- Data Verification: Quality Assurance and Reach a Conclusion

To enquire more about our research process and report store, please connect @
https://www.analystviewmarketinsights.com/get-in-touch/

About Us
AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends for various industries such as Healthcare, Bulk Chemicals, Semiconductors, Electronics, and Foods and Beverages.

Contact Us
Mr. Jose (Press & Marketing Manager)
Corporate Sales, USA
AnalystView Market Insights
Email: sales@analystviewmarketinsights.com
Tel: +91-757-498-5725 (Asia-Pacific Business Centre)
Web: www.analystviewmarketinsights.com

This release was published on openPR.